Kay Schwichtenberg | CEO of Central Life Sciences

Kay-SchwichtenbergKay has more than 30 years of experience in the profitable commercialization and development of life sciences products for the public health, animal pharmaceutical and consumer packaged goods markets.

With proven managerial and strategic agility in global technology sourcing, particularly in Japan and Europe, Kay has successfully led organizations in entrepreneurial, start-up enterprises and in large, public corporate environments with Sandoz Corporation (now Novartis), Brunswick corporation and Central Garden and Pet (NASDAQ:CENT).

Kay is accomplished leader of organizations in regulated industries and is facile in driving new product portfolio development, manufacturing start -up and facilitating new product introductions through the U.S. FDA and EPA processes. She has negotiated asset divestitures with the Federal Trade Commission and has driven strategy for major business issues with the national media that threatened to jeopardize product integrity. She has successfully driven cultural change resulting from managing multiple mergers and acquisitions.

Kay was an Ambassadorial Rotary Fellow at the University of Brussels, completed in the Advanced Business Programme at the London School of Business and has an MBA from the University of Illinois at Chicago and a BA from St. Norbert College. She serves on several boards, including the University of Illinois Foundation and the American Pet Products Association where she is the former chairman. She is a sought after speaker on the topic: Incubate! How Leadership Drives Technology to Market.